US Congressman Welcomes India’s Decision to Resume Export of Surplus Covid Vaccine

0


“I welcome today’s announcement by the Indian government to resume exports of COVID-19 vaccines,” Congressman Gregory Meeks, chairman of the powerful House of Representatives foreign affairs committee, said on Monday in a tweet. (Representative image)

An influential member of the US Congress hailed India’s decision to resume exporting surplus COVID-19 vaccines to meet its commitment to the global COVAX pool.

Indian Health Minister Mansukh Mandaviya said on Monday that the country will resume COVID-19 surplus vaccine exports in the fourth quarter of this year under the ‘Vaccine Maitri’ program to meet its commitment to the global COVAX pool . He said, however, that vaccinating his own citizens remains the government’s top priority. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations and the WHO.

“I welcome today’s announcement by the Indian government to resume exports of COVID-19 vaccines,” Congressman Gregory Meeks, chairman of the powerful House of Representatives foreign affairs committee, said on Monday in a tweet.

“As the world’s largest vaccine maker, India’s role is critical in beating this pandemic,” Meeks tweeted, tagging a New York Times article. India had halted the export of COVID-19 vaccines after the second wave of the COVID-19 pandemic hit the country in April this year.

Get live stock quotes for BSE, NSE, US market and latest net asset value, mutual fund portfolio, see the latest IPO news, top IPOs, calculate your tax with the help of the income tax calculator, know the best winners, the best losers and the best equity funds in the market. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay up to date with the latest news and updates from Biz.



Leave A Reply

Your email address will not be published.